?? Exciting Update! ?? We are thrilled to announce that RNT Health Insights has been selected as one of the six winners of the Pfizer INDovation NIPER-A edition! This initiative, led by Pfizer and Social Alpha in partnership with the Department Of Pharmaceuticals, NIPER Ahmedabad, Atal Innovation Mission Official and NITI Aayog, supports healthcare start-ups committed to solving critical healthcare challenges through affordable, easy-to-use diagnostic devices, making healthcare more accessible for all. As part of this program, we are grateful to receive grant-in-aid, incubation, and product development support to fast-track our clinical validation and regulatory submissions, significantly reducing the time to market for our breakthrough Early Gastric Cancer detection technology. Additionally, we are pleased to announce that at the Pfizer INDovation winners ceremony, the honorable Secretary of the Department of Pharmaceuticals, Dr. Arunish Chawla, approved RNT Health Insights, along with the other five winners of the program, for funding and clinical validation support under Component B3 of the PRIP scheme (Promotion of Research and Innovation in Pharma-MedTech) and the Meditech initiative. The objective of this scheme is to transform the Indian MedTech sector by encouraging innovation-based growth and strengthening India’s research infrastructure, ensuring that breakthrough medical devices can reach the market faster and at scale. We extend our sincere gratitude to the entire team at Pfizer, Social Alpha, Department Of Pharmaceuticals, and NIPER Ahmedabad for this incredible opportunity and for trusting in RNT Health Insights' vision to reduce the burden of gastrointestinal cancers. Read more: https://lnkd.in/gDTAEvQm Stay tuned as we continue our mission to redefine early gastric cancer detection and push the boundaries in gastrointestinal diagnostics! ?? Ria Khurana | Tanmaya Gulati | Manoj Kumar | Dr Mrigank Warrier | Dr. Kshama Kothari | Pragyan Pani | Krishna Sree | Meenakshi Nevatia | Sharad Goswami | Sneha Senapati | Roma Nair | Vincent Lamoureux
关于我们
At RNT Health Insights, we are dedicated to enhancing gastrointestinal diagnostics with cutting-edge technology. We are developing AI-assisted diagnostic tools to aid endoscopists in the real-time detection of upper gastrointestinal lesions, including early gastric cancer and associated malignant lesions. Our Early Gastric Cancer detection technology, recognised with the US FDA Breakthrough Device Designation, aims to enhance diagnostic precision and improve patient outcomes. By seamlessly integrating AI with endoscopy, we strive to reduce missed diagnoses and improve patient prognosis through timely intervention.
- 网站
-
www.rntinsights.com
RNT Health Insights的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 2-10 人
- 总部
- Chandigarh
- 类型
- 私人持股
- 创立
- 2022
地点
-
主要
IN,Chandigarh
RNT Health Insights员工
动态
-
We’re excited to share that RNT Health Insights had the privilege?of participating in the prestigious International Knowledge Millennium Conference (IKMC) 2024, organised by IKP Knowledge Park to celebrate their 25th anniversary. This event provided a valuable platform to engage with innovators, scientists, and leaders in biotechnology and healthtech, all driven by a shared commitment to advancing transformative healthcare solutions. We are deeply honoured to have received two major recognitions at the event: the IKP Future Stars Under 25 Grant Award (INR 5 lacs) and First Position in the Healthtech Category at the Startup Exhibition (INR 1 lac). IKMC 2024 marked a significant milestone, celebrating IKP’s 25-year legacy of fostering pioneering science and supporting ideas that are shaping the future of healthcare. The event was filled with invaluable learning experiences, and we would like to express our sincere gratitude to Sridhar Ramanathan, Aaqib Jameel, and the entire IKP Knowledge Park ecosystem for their unwavering support and guidance in propelling our mission forward. Stay tuned as we continue our mission to redefine early gastric cancer detection and push the boundaries in gastrointestinal diagnostics! ??
-
We are excited to announce that RNT Health Insights has been invited to present our innovation at the prestigious 2024 Mayo Clinic Beahrs Surgical Innovation Summit. This event serves as an accelerator for innovation by bringing together each facet of industry startups, venture capitalists, Mayo Clinic surgeons and administrators — to solve unmet needs in surgical care. During the summit, we will have the opportunity to engage with key opinion leaders and showcase our groundbreaking advancements in enhancing the detection and treatment of gastrointestinal cancers through endoscopic procedures. We are immensely grateful for this opportunity and look forward to forging valuable partnerships and gaining insights that will propel our mission forward. Exciting times ahead- stay tuned for more updates as we revolutionize gastrointestinal care! ??? https://lnkd.in/gdDu9frU
2024 Mayo Clinic Beahrs Surgical Innovation Summit - Start Ups
https://www.youtube.com/
-
Thrilled to announce RNT Health Insights as one of the first 9 startups funded by WTFund! ?? RNT Health Insights is pioneering AI-assisted diagnostic software to significantly improve the detection and diagnosis of gastrointestinal (GI) lesions, including early gastric cancer, during endoscopic procedures. Their technology serves as a crucial support system for gastroenterologists, identifying and characterizing lesions in real-time. We are particularly excited about RNT Health Insights' potential, driven by their market-ready technology, strategic partnerships, and the FDA Breakthrough Device Designation that provides an expedited regulatory pathway. Led by MBBS co-founders and supported by senior gastroenterologists, RNT Health Insights is set to transform GI diagnostics. We’re proud to back this innovative team as they push the boundaries of healthcare technology! ?? #WTFund #WTFunded
-
?? Excited to announce that CCAMP-incubated startup BioCompute Inc has made it to the inaugural cohort of @TheWTFund "Innovators Under 25" grantees! RNT Health Insights (under the BREC Programme) also made it to the list securing up to INR 20 lakh in non-equity grants! WTFund is India's first non-equity grant fund, which was launched by entrepreneur Nikhil Kamath. Biocompute develops affordable DNA data storage chips, revolutionising data centre efficiency, while RNT Health Insights is an AI-assisted diagnostic software for gastrointestinal cancer detection. Read more: https://lnkd.in/gpQ8896H Taslimarif Saiyed, PhD Department of Biotechnology
-
?Exciting News!? We are thrilled to announce that RNT Health Insights has been selected for the prestigious WTFund program, backed by Nikhil Kamath, co-founder of Zerodha, Gruhas and True Beacon! WTFund is India's premiere non-dilutive grant fund program designed to empower emerging young entrepreneurs under 25 by providing them with a non-dilutive grant, mentorship and guidance from industry leaders and access to strategic partnerships with top companies. The selection process was extremely insightful and rigorous with an acceptance rate of <1%. A special thanks to Harnidh Kaur (孔知韵), Suchet Kumar, Vivek Kamath, Arshia Mal and the entire WTFund team for their belief in our vision. With their trust and support, we look forward to reaching new heights at RNT Health Insights, spearheading the process of bringing to market our breakthrough medical devices for the improved detection and treatment of gastrointestinal cancers. We’re just getting started, and the best is yet to come!??
-
RNT Health Insights: Breakthrough AI-assisted diagnostic technology which detects lesions indicative of Early Gastric Cancer in real-time during upper GI endoscopy. Watch their pitch video and like it on YouTube to increase their chances of winning! https://lnkd.in/gqBz4YRY Tanmaya Gulati Ria Khurana #mtiapac2024 #mtiapac #mti #videos #1minvideos #medtech
RNT Health Insights - One Minute Video Competition 2024
https://www.youtube.com/
-
Introducing #TSEC's #TOP50 trailblazers who are redefining business with a conscience! ?? From cutting-edge biomedical technology to sustainable fashion from Agri-waste, their solutions span diverse sectors??. But their common thread? A commitment to creating positive change. Whether it’s #empowering #communities, championing health and safety, or reimagining education, these enterprises are leaving an indelible mark! Stay tuned for more updates as we continue to spotlight their incredible work. #TSEC #socialenterprise #changemakers #entrepreneurship #innovation #inclusiveecosystem #sustainablebusiness #community
-
Unveiling the Bharat Pitchathon - Emerging Startups of the Year 2024! ?? We are thrilled to unveil the most promising startups that have emerged from Bharat Pitchathon 3.0! ?? These innovative ventures are set to redefine industries, create impact, and showcase the incredible talent that lies within our nation. This year's cohort has brought forward groundbreaking ideas and solutions across diverse sectors, from tech and healthcare to sustainability and beyond. Witness the rise of these startups as they gear up to scale new heights and make a difference. Follow their journey and cheer them on as they take bold steps towards success. These startups are not just businesses; they are the future of India's entrepreneurial landscape. Let's support their visions and celebrate their achievements! #BharatPitchathon #India #Slush #EmergingStartupsOfTheYear #Innovation #Growth #Startups #Founders #Investors #Pitchers Gautham Roopali Tushar Amit Ujjwal Netra Vaniya Ruchi Vageesh
-
At RNT Health Insights, we are thrilled to announce our emergence from stealth mode with the achievement of a significant milestone: our Early Gastric Cancer detection technology has been granted the prestigious Breakthrough Device Designation by the US Food and Drug Administration (FDA). Gastric cancer remains a major global health challenge, being the fourth leading cause of cancer-related mortality, with a five-year survival rate of less than 40%. Early and accurate detection can increase this rate to 90%. Despite being the gold standard, Gastrointestinal endoscopic procedures have a miss rate of 4.6-25.8% for gastric cancers, depending on the endoscopist’s experience. Our Early Gastric Cancer detection technology, with a detection accuracy of 96% based on preclinical validation, aims to significantly improve diagnostic accuracy during real-time endoscopic procedures. This designation is a testament to our innovative solution designed to detect lesions indicative of Early Gastric Cancer, as well as associated malignant lesions, in real-time during standard endoscopy examinations. This recognition highlights the potential of our technology to significantly advance the diagnosis of life-threatening conditions, providing timely and accurate detection that could greatly improve patient outcomes. The Breakthrough Device Designation not only highlights the clinical potential of our technology but also provides an accelerated regulatory pathway, allowing us to expedite our device development and bring our life-saving innovation to market more quickly. For more details, please refer to the following featured press releases: Business Standard: https://lnkd.in/ggfJustc The Print: https://lnkd.in/gGKkimpf Press Trust of India: https://lnkd.in/gfXQcSca Business Wire India: https://lnkd.in/gJ5xSzY6 Kalkine Media: https://lnkd.in/gFkcaynd Stay tuned for more updates. RNT Health Insights | Tanmaya Gulati | Ria Khurana | IKP EDEN | MedTech Innovator | MedTech Innovator Asia Pacific